Skip to main content
Log in

Ciprofloxacin/diclofenac/dipyrone

Toxic epidermal necrolysis treated with human gamma globulin: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Pulido-Diaz N, Angulo-Alvarez DM, Lopez-Ibarra M.[Human gamma globulin in toxic epidermal necrolysis]. [Spanish]. Revista Medica el Instituto Mexicano del Seguro Social 50: 59-62, No. 1, Jan 2012 - Mexico

Download references

Additional information

Key words

Dipyrone; therapeutic use; Diclofenac; Ciprofloxacin; treatment; adverse reactions; drug-induced; Gammaglobulin; Toxic-epidermal-necrolysis

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciprofloxacin/diclofenac/dipyrone. React. Wkly. 1428, 14 (2012). https://doi.org/10.2165/00128415-201214280-00046

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214280-00046

Keywords

Navigation